Skip to content

SATSUMA PHARMACEUTICALS, INC.: filings

Every SATSUMA PHARMACEUTICALS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 15 filings, each linked to its SEC index.

Filing record ends 2023-05-11

The latest filing in this captured record is a 10-Q filed 2023-05-11. No later filing is in the SEC companyfacts record captured on 2026-09-22. SATSUMA PHARMACEUTICALS, INC. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2023-05-11fiscal Q1 202338750000950170-23-021208
10-K2023-03-28fiscal FY 202242810000950170-23-010338
10-Q2022-11-03fiscal Q3 2022401120001564590-22-036617
10-Q2022-08-09fiscal Q2 2022401090001564590-22-028770
10-Q2022-05-10fiscal Q1 202237740001564590-22-019290
10-K2022-03-15fiscal FY 202137740001564590-22-010433
10-Q2021-11-09fiscal Q3 202135940001564590-21-055814
10-Q2021-08-10fiscal Q2 202135910001564590-21-043085
10-Q2021-05-11fiscal Q1 202135730001564590-21-026571
10-K2021-03-25fiscal FY 202038920001564590-21-015557
10-Q2020-11-10fiscal Q3 202036900001564590-20-053010
10-Q2020-08-11fiscal Q2 202036930001564590-20-039324
10-Q2020-05-12fiscal Q1 202035730001564590-20-024703
10-K2020-03-10fiscal FY 2019381110001564590-20-009753
10-Q2019-11-12fiscal Q3 201935880001564590-19-042959

Inspect the source

Entity
SATSUMA PHARMACEUTICALS, INC. / CIK 0001692830
Captured
SEC response SHA-256
dbd6bf5259de8abe94a8d3b074da323f50f152ca1e5e49542ffff79e1c86f460

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001692830.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))